Cuprina Holdings (Cayman) LTD (NASDAQ:CUPR) Sees Large Growth in Short Interest

Cuprina Holdings (Cayman) LTD (NASDAQ:CUPR) saw a large increase in short interest during the month of October. As of October 15th, there was short interest totaling 14,383 shares, an increase of 357.9% from the September 30th total of 3,141 shares. Based on an average daily volume of 74,972 shares, the days-to-cover ratio is currently 0.2 days. Currently, 0.2% of the company’s shares are short sold.

Wall Street Analyst Weigh In

Separately, Weiss Ratings lowered shares of Cuprina Holdings (Cayman) from a “sell (d-)” rating to a “sell (e+)” rating in a report on Tuesday, October 13th. One analyst has rated the stock with a Sell rating. According to data from MarketBeat, Cuprina Holdings (Cayman) has a consensus rating of “Sell”.

Cuprina Holdings (Cayman) Stock Performance

Shares of Cuprina Holdings (Cayman) stock opened at $1.85 on Wednesday. Cuprina Holdings has a one year low of $1.45 and a one year high of $14.80. The stock’s 50-day moving average is $2.36 and its 200 day moving average is $3.03.

Cuprina Holdings (Cayman) Company Profile

Cuprina Holdings (Cayman) Limited is a medical technology company focused on developing and commercializing products for wound care and related medical applications. The company’s technologies are designed to support the management of wounds, including products intended to help control bleeding and promote the healing process.

Cuprina’s product portfolio is based on biomaterials and biological components, including technologies derived from animal blood, and is intended for use by healthcare professionals in clinical and surgical settings.